First Alzheimer’s Blood Test Available in US in June

The first blood test to help diagnose Alzheimer’s disease will be available from late June in the US following regulatory clearance for its use last week, according to the Japanese company behind the innovation.

The test will initially be available at about 50 American research institutes and hospitals that specialize in Alzheimer’s disease, Goki Ishikawa, head of Fujirebio Holdings Inc., a unit of Japan’s H.U. Group Holdings Inc., said in an interview Tuesday. It’s partnering with bigger rivals like Beckman Coulter Inc. to help develop and manufacture their products, he said.